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Abstract
Objective: To characterize and compare ambulatory antibiotic prescribing for children in U.S. 
pediatric and non-pediatric Emergency Departments (EDs).
Methods: A cross-sectional retrospective study of patients aged 0–17 years discharged from U.S. 
EDs was conducted using the 2009–2014 National Hospital Ambulatory Medical Care Survey ED 
data. We estimated the proportion of ED visits resulting in antibiotic prescriptions, stratified by 
antibiotic spectrum, class, diagnosis, and ED type (pediatric defined as >75% of visits by patients 
aged 0–17 years, versus non-pediatric). Multivariable logistic regression was used to determine 
factors independently associated with first-line, guideline-concordant prescribing for acute otitis 
media, pharyngitis, and sinusitis.
Results: In 2009–2014, of the 29 million mean annual ED visits by children, 14% (95% CI: 10–
20%) occurred at pediatric EDs. Antibiotics overall were prescribed more frequently in non-
pediatric than pediatric ED visits (24% versus 20%, p<0.01). Antibiotic prescribing frequencies 
were stable over time. Of all antibiotics prescribed, 44% (95% CI: 42–45%) were broad-spectrum, 
and 32% (95% CI: 30–34%, 2.1 million per year) were generally not indicated. Compared to 
pediatric EDs, non-pediatric EDs had a higher frequency of prescribing of macrolides (18% versus 
8%, p<0.0001) and lower frequency of first-line, guideline-concordant prescribing for the 
respiratory conditions studied (77% versus 87%, p<0.001).
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Conclusions: Children are prescribed almost 7 million antibiotic prescriptions in EDs annually, 
primarily in non-pediatric EDs. Pediatric antibiotic stewardship efforts should expand to non-
pediatric EDs nationwide, particularly regarding avoidance of antibiotic prescribing for conditions 
for which antibiotics are not indicated, reducing macrolide prescriptions, and increasing first-line, 
guideline-concordant prescribing.
Introduction
Approximately 18% of U.S. children visited an Emergency Department (ED) in 2012.1 
Children in EDs often receive antibiotics, which are estimated to be prescribed in 15–20% of 
the >26 million annual pediatric visits to U.S. EDs.2–5 Respiratory conditions account for 
>70% of antibiotic prescriptions for children in the ambulatory setting.4 Previous work 
shows that the majority of antibiotics prescribed to children in ambulatory settings are 
broad-spectrum and approximately 30% are not in accordance with national guidelines.6–9
The National Action Plan for Combating Antibiotic-Resistant Bacteria aims to reduce 
inappropriate antibiotic use by 50% in ambulatory settings, including EDs, by 2020.10,11 
However, formal antibiotic stewardship efforts specific to ambulatory and ED settings are 
lacking nationally.12,13
Over 80% of pediatric visits to an ED occur in non-academic EDs or general (i.e., non-
pediatric) EDs.2,14,15 Children with asthma, bronchitis, and croup receive higher quality of 
care and fewer unnecessary chest x-rays when treated at a pediatric ED compared to a non-
pediatric ED.16 Previous work has demonstrated lower frequency of antibiotic prescribing 
for children with febrile respiratory illness visits in pediatric EDs compared to non-pediatric 
EDs.17 However, an understanding of the overall landscape of antibiotic prescribing for 
children presenting to pediatric and non-pediatric EDs nationally is both lacking and 
necessary to guide efforts to improve antibiotic prescribing for children in EDs.
We aimed to provide a comprehensive characterization of antibiotic use for children in 
pediatric and non-pediatric EDs nationally by the type of agent prescribed, the diagnoses 
associated with antibiotic visits, and concordance with national guideline recommendations 
for first-line treatment of common respiratory infections.
Methods
Study Design and Data Source
We performed a cross-sectional retrospective study using the National Hospital Ambulatory 
Medical Care Survey (NHAMCS) ED public-use data files from 2009–2014 (the most recent 
available data at study onset).18 NHAMCS is conducted annually by the National Center for 
Health Statistics from a sample of non-federal hospital-based EDs, including representation 
from freestanding pediatric facilities.19 The survey uses a multistage probability sampling 
design in selecting participating hospitals and patient visits across the U.S. Data for sampled 
visits are collected during a 4-week reporting period, weighted to produce national 
estimates, and classified by U.S. Census Region.20 Participating centers had an unweighted 
ED survey response rate of 75.5–92.0% over the study period.
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Survey variables used included demographics (age, gender, and race), insurance status 
(private versus non-private), provider type (physician versus advanced practice provider), 
U.S. Census Region, ED metropolitan statistical area (MSA) status, discharge diagnosis, and 
medications administered, prescribed or continued at ED visits. MSA is defined by the 
Office of Management and Budget as geographical regions with high population densities. 
Diagnoses were determined by International Classification of Diseases, 9th revision (ICD-9) 
codes. Duration of therapy and route of medication administration were unavailable; 
medications available only in topical formulations were omitted. For consistency across all 
included survey years, the first 3 diagnosis fields and 8 medications were considered.
Study Participants and Setting
Visits for all patients aged 0–17 years discharged from the ED were included. Antibiotic 
visits were defined as ED visits in which systemic (oral or parenteral) antibiotics were 
mentioned as continued, administered, or prescribed. Civilian non-institutionalized 
population data from the U.S. Census Bureau21 were used to determine antibiotic visits per 
1000 U.S. population. We estimated each ED’s proportion of pediatric visits by calculating 
the weighted proportion of visits by children out of total ED visits. The ED type was then 
defined as pediatric if >75% of all visits to that ED were by patients aged 0–17 years, or 
non-pediatric otherwise, a definition used for classifying pediatric EDs previously.2,22,23 A 
histogram of the proportion of weighted pediatric visits by ED (Supplemental Figure 1) 
indicates most EDs defined as pediatric had >90% of visits by children; thus our definition 
appears to accurately differentiate pediatric EDs from others.
Diagnoses for Antibiotic Visits
The NHAMCS dataset does not link medications with diagnoses. Based on a previously 
published classification system informed by national guideline recommendations, we 
assigned the top 3 listed diagnoses to one of three tiers: diagnoses for which antibiotics were 
(1) almost always indicated (e.g., bacterial pneumonia), (2) may be indicated (e.g., 
pharyngitis), or (3) generally not indicated (e.g., bronchiolitis/bronchitis).5 Each visit was 
assigned a single diagnosis, with priority given hierarchically to tier 1 diagnoses, then tier 2 
diagnoses, then tier 3 diagnoses. If a visit had multiple diagnoses from a single tier, the first-
listed diagnosis was assigned.
Because >70% of ambulatory pediatric antibiotic prescribing is for acute respiratory tract 
infection (ARTI), we evaluated prescribing for ARTIs.4 We defined ARTI to include 
pneumonia, acute otitis media (AOM), non-suppurative otitis media, sinusitis, pharyngitis 
(including viral and streptococcal), non-specific upper respiratory tract infection, bronchitis/
bronchiolitis, and influenza.5
Classification of Antibiotic Spectrum and First-Line, Guideline-Concordant Prescribing
Antibiotic types were classified by their generic components and therapeutic classes using 
Multum Lexicon® Drug Database. Antibiotics included: penicillins, cephalosporins, 
macrolides, quinolones, lincomycin derivatives, tetracyclines, sulfonamides, urinary anti-
infectives (e.g., nitrofurantoin), aminoglycosides, carbapenems, linezolid, and vancomycin. 
The general class of antibiotics (e.g. penicillins) and sub-classes (e.g. 1st generation 
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cephalosporins) were determined using Multum Level 2 and Level 3 categories, respectively. 
The following antibiotics and antibiotic classes were considered narrow-spectrum: 
penicillin, amoxicillin, 1st generation cephalosporins, sulfonamides, and nitrofurantoin. All 
other antibiotics, including macrolides and combination beta-lactam/beta-lactamase 
inhibitors such as amoxicillin-clavulanate, were considered broad-spectrum.
The diagnoses of AOM, pharyngitis, and sinusitis are common respiratory illnesses, and 
have evidence-based clinical practice guidelines that recommend specific and primarily 
narrow-spectrum antibiotic options as first-line therapy.24–26 Based on national guidelines, 
we defined first-line, guideline-concordant antibiotic use as amoxicillin or amoxicillin-
clavulanate for AOM and sinusitis, and penicillin or amoxicillin for pharyngitis. 
Amoxicillin-clavulanate was included as first-line for AOM due to recommendations to use 
it first-line for selected patients, e.g., for children with concurrent conjunctivitis.
Analysis
We studied three main outcomes. First, using NHAMCS-provided patient visit weights, we 
estimated the proportion and mean annual number of ED visits resulting in an antibiotic 
prescription, called antibiotic visits. We stratified antibiotic visits by patient demographic 
characteristics, patient insurance type, provider type, U.S. Census Region, ED MSA status, 
and ED type. Six years of survey data were combined to increase sample size for analyses 
stratified by age. Second, we compared the proportion of antibiotic visits and antibiotic 
classes for ARTI, urinary tract infection (UTI), skin and soft tissue infection (SSTI) and 
diagnostic tier by pediatric and non-pediatric EDs. All pediatric age groups were combined 
for the analysis of antibiotic use by diagnosis to increase the sample size and produce 
reliable estimates as suggested in the NHAMCS use files.27 We assessed trends in 
proportion of antibiotic classes over time using logistic regression in 2-year increments 
(2009–10, 2011–12, and 2013–14) as the predictor variable and percent of antibiotics by 
class as the outcome. Finally, based on previous work in ambulatory settings demonstrating 
factors associated with antibiotic prescribing,4,28–30 we used multivariable logistic 
regression, adjusting for patient demographic characteristics, patient insurance type, 
provider type, U.S. Census Region, ED type, and diagnoses, to determine factors 
independently associated with the outcome of first-line, guideline-concordant prescribing for 
AOM, pharyngitis, and sinusitis. Odds ratio estimates for first-line guideline-concordant 
prescribing by MSA were also determined. Data on MSA were not publicly available in 
2012; therefore, odds ratio estimates for MSA were determined using a separate model that 
adjusted for all other variables, but excluded observations from 2012.
We performed statistical analyses using STATA 14® (STATA Corp, College Station, TX) 
accounting for the complex survey design, including patient visit weights, strata, and 
primary sampling unit design variables. Estimates were not calculated if based on <30 visits 
or if the relative standard error was <0.3, as recommended by NHAMCS standards for 
reliability and precision.27 Antibiotic prescribing proportions were compared using chi-
square tests for heterogeneity. Ninety-five percent confidence intervals (CI) were calculated 
for all estimates. Significance was considered at 2-sided P value ≤0.05. NHAMCS data sets 
used in this analysis are de-identified and publically available and thus were determined 
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non-human subjects by the Human Subjects Advisor at the National Center for Emerging 
and Zoonotic Infectious Diseases.
Results:
Characteristics of Pediatric Visits to EDs
In 2009–2014, an average 29 million (95% CI: 27–32 million) ED visits by children 
occurred annually, of which 23% (95% CI: 22–24%) were antibiotic visits, accounting for an 
estimated 6.7 million (95% CI: 6.1–7.5 million) antibiotic visits annually (Table 1). Fourteen 
percent (95% CI: 10–20%) of ED visits occurred in pediatric EDs. The percentage of ED 
visits resulting in an antibiotic prescription was significantly higher in non-pediatric EDs 
(24%, 95% CI: 23–25%) compared to pediatric EDs (20%, 95% CI: 17–22%, p<0.01).
Diagnoses Associated with Antibiotic Visits
ARTIs accounted for the majority of diagnoses among antibiotic visits (55%, 95% CI: 54–
57%), followed by SSTI (9%, 95% CI: 8–10%) and UTI (7%, 95% CI: 6–8%). AOM and 
pharyngitis accounted for 45% (95% CI: 42–47%) and 25% (95% CI: 23–27%) of all ARTI 
antibiotic visits, respectively. Pediatric and non-pediatric EDs had similar proportion of 
antibiotic visits for ARTI, SSTI, and UTI (Table 2).
Of antibiotic visits for children in EDs nationally, 32% (95% CI: 30–34%; 2.1 million/year) 
were for conditions for which antibiotics are generally not indicated. There were no 
significant differences in the proportion of visits in each diagnostic tier (antibiotics almost 
always, may be, or generally not indicated) for children in pediatric versus non-pediatric 
EDs (Table 2). However, non-pediatric EDs had significantly more antibiotic visits for 
diagnoses for which antibiotics are generally not indicated (33%, 95% CI: 31–34%) 
compared to pediatric EDs (26%, 95% CI: 21–31%, p=0.02).
Antibiotic Classes Prescribed at ED Visits
Narrow-spectrum penicillins were the most commonly prescribed antibiotic class in visits to 
both pediatric and non-pediatric EDs, followed by cephalosporins, macrolides, 
sulfonamides, and lincomycin derivatives (clindamycin) (Figure 1). Fluoroquinolones 
comprised 2% (95% CI: 2–3%) and tetracyclines, urinary anti-infectives, and 
aminoglycosides together comprised 3% (95% CI: 3–3%) of antibiotic prescriptions in all 
EDs; prescribing estimates for these agents in pediatric EDs did not meet NHAMCS 
standards for reliability or precision due to sample size. There was no significant change 
over time in the percent of any one antibiotic class of all antibiotics prescribed (Figure 2).
Macrolides were prescribed in 17% (95% CI: 16–19%; 1.1 million) of all visits to EDs in 
which antibiotics were prescribed. Among antibiotic visits, the diagnoses most frequently 
associated with macrolides included AOM (17%, 95% CI: 14–20%), non-viral pneumonia 
(14%, 95% CI: 12–17%), pharyngitis/tonsillitis (12%, 95% CI: 10–14%), bronchitis/
bronchiolitis (11%, 95% CI: 9–13%), and upper respiratory tract infection (10%, 95% CI: 8–
13%). Of all ED macrolide prescribing to children, 44% (95% CI: 41–47%; 500,000 
annually) were for diagnoses for which antibiotics are generally not indicated. Macrolides 
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were prescribed at a significantly higher frequency in non-pediatric EDs (18%, 95% CI: 17–
20%) compared to pediatric EDs (8%, 95% CI: 6–10%, p<0.0001, Figure 1).
Broad-spectrum antibiotics were prescribed in 44% (95% CI: 42–45%) of antibiotic visits by 
children in EDs nationally, with no difference between non-pediatric (44%, 95% CI: 42–
45%) versus pediatric (44%, 95% CI: 40–48%, p=0.91) EDs.
Characteristics of First-Line, Guideline-Concordant Therapy
Among children with AOM, sinusitis, or pharyngitis, the proportion of antibiotic visits 
during which patients received first-line, guideline-concordant therapy was 78% (95% CI: 
76–80%) and was higher in pediatric EDs (87%, 95% CI: 82–90%) than non-pediatric EDs 
(77%, 95% CI: 75–79%, p<0.001, Table 3). This difference persisted in the multivariable 
model for the percent of AOM, pharyngitis, or sinusitis visits prescribed first-line, guideline-
concordant therapy with an adjusted odds ratio (aOR) of 2.01 (95% CI: 1.38–2.92) for 
pediatric EDs compared to non-pediatric EDs. First-line, guideline-concordant antibiotic 
prescribing was also significantly more likely in visits by black children (aOR 1.56, 95% CI: 
1.15–2.11) compared to visits by white children. First-line, guideline-concordant antibiotic 
prescribing was significantly lower in the Midwest (aOR 0.51, 95% CI: 0.34–0.77), South 
(aOR 0.46, 95% CI: 0.32–0.67) and West (aOR 0.55, 95% CI: 0.35–0.87) when compared to 
the Northeast region (Table 3). Patients with sinusitis and pharyngitis had lower adjusted 
odds of receiving first-line antibiotic treatment (aOR 0.51, 95% CI: 0.32–0.82 and aOR 
0.72, 95% CI: 0.53–0.96, respectively) compared to patients with AOM. The percent of 
AOM, sinusitis, and pharyngitis visits with first-line, guideline-concordant prescribing did 
not change over the study period (Supplemental Figure 2a).
Discussion:
This study provides a comprehensive overview of antibiotic use among visits involving 
children in U.S. EDs. Non-pediatric EDs care for >85% of pediatric ED patients (over 25 
million visits annually), and consequently prescribe antibiotics in >6 million annual 
pediatric visits — nearly 10% of all pediatric outpatient antibiotic prescriptions.9 Compared 
to visits in pediatric EDs, clinicians in non-pediatric EDs prescribe antibiotics more 
frequently for conditions for which antibiotics are likely unnecessary, are more likely to 
select macrolides, and are less likely to select first-line, guideline-recommended antibiotics 
for children with common respiratory illnesses.
While the proportion of children with viral infections receiving unnecessary antibiotics has 
been as low as 2.5% in selected, large, academic pediatric EDs,31 we evaluated all ED visits 
nationally, and found 26% of antibiotic visits at pediatric EDs were for conditions for which 
antibiotics were generally not indicated. Our finding mirrors previous work on antibiotic 
prescribing for children with ARTI in the ambulatory and ED setting.4,32 In comparison, we 
found that 33% of antibiotic visits at non-pediatric EDs were for conditions for which 
antibiotics were generally not indicated, accounting for an estimated 2 million unnecessary 
pediatric antibiotic prescriptions annually. Antibiotic prescribing for these conditions 
provides no benefit to patients, puts them at unnecessary risk for adverse events, and should 
be a target for quality improvement in EDs nationally, particularly in non-pediatric EDs.
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More frequent unnecessary and guideline-discordant antibiotic prescribing by clinicians in 
non-pediatric EDs may reflect differences in clinical experiences during training. The 
American Academy of Pediatrics has published multiple evidence-based clinical practice 
guidelines for common pediatric conditions, created with multidisciplinary expert 
consensus, including representation from pediatric emergency medicine. ARTIs constitute 
the majority of antibiotic visits for children in EDs nationally, as is the case among 
outpatients seen by pediatric clinicians.4,33 Pediatric-trained clinicians are more likely to 
work in pediatric EDs compared to non-pediatric EDs,34,35 and might thereby have 
increased familiarity and compliance with pediatric-specific guidelines, which could 
contribute to differences in quality of antibiotic prescribing between pediatric and non-
pediatric EDs. Previous work shows children are more likely to receive unnecessary 
antibiotics for upper respiratory tract infections in EDs or family practitioner offices 
compared to pediatrician offices.36 Increased exposure of emergency medicine clinicians to 
pediatric-focused guidelines and antibiotic stewardship initiatives is an important strategy to 
improve antibiotic prescribing quality in non-pediatric EDs.
We found that broad-spectrum antibiotics constitute almost half (47%) of all antibiotics 
prescribed to children in the ED. Previous work has shown similar rates of broad-spectrum 
antibiotic prescribing for children in other ambulatory settings and in the ED with 
respiratory tract infections specifically.4,32 In our study, macrolides accounted for 17% of all 
antibiotics prescribed to children in EDs, and non-pediatric EDs prescribed macrolides 
significantly more often than pediatric EDs (18% vs. 8%, respectively). Our work adds to a 
growing body of literature demonstrating that non-pediatric healthcare centers and clinicians 
prescribe macrolides more frequently than pediatric healthcare centers and clinicians.37–40 
In our study, macrolides were most commonly prescribed for AOM; however, macrolides are 
not recommended for AOM treatment.24 Streptococcus pneumoniae is the most common 
cause of AOM and sinusitis, yet41 approximately 30% of U.S. invasive S. pneumoniae 
isolates are resistant to macrolides,42 so macrolides represent a suboptimal treatment choice 
for these conditions. Bronchitis/bronchiolitis and upper respiratory tract infections, 
diagnoses for which antibiotics are not recommended,43–46 constituted 21% of all macrolide 
use in our study. Inappropriate macrolide use should be a target for improvement in 
antibiotic prescribing for children in EDs, and non-pediatric EDs in particular.
The Centers for Disease Control and Prevention’s Core Elements of Outpatient Antibiotic 
Stewardship47 offers a framework for implementing antibiotic stewardship in outpatient 
settings, including EDs. Additionally, EDs can improve their antibiotic prescribing through 
standardized clinical pathways for guideline-concordant antibiotic prescribing and quality of 
care, clinical decision support tools, and clinical justification for non-recommended 
antibiotic use.47,48
We acknowledge several possible limitations to this study. First, our study period from 
2009–2014 captured the most recent survey data available at the time of the analysis. 
Although prescribing patterns could have changed in the interim, the trend in antibiotic 
prescribing did not change significantly during the study period (Supplemental Figure 2b). 
Second, indications for antibiotics were based on the three diagnosis codes available in the 
NHAMCS dataset, which were not directly linked to medications mentioned during the visit. 
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The hierarchical classification system used was designed to categorize the most likely 
diagnosis for which the antibiotic was prescribed. However, it is possible that a small 
proportion of antibiotic visits grouped as ‘generally not indicated’ might still warrant 
antibiotic prescribing, such as visits among patients with sickle-cell disease and fever. Third, 
patient allergies to medications are not captured in the NHAMCS dataset, which could 
influence the antibiotic class prescribed. However, patient antibiotic allergies would be 
expected to occur at similar rates in pediatric and non-pediatric EDs. Fourth, longitudinal 
patient data were not available, nor were data on provider specialty. Finally, although our 
definition of pediatric EDs has been used previously2,22,23 and is likely quite specific 
(Supplemental Figure 1), some large non-pediatric EDs might have a specific pediatric 
subsection that constitutes the minority of visits but is nonetheless staffed by pediatric 
specialists.
In summary, in this nationally representative study of all ED visits by children, we found the 
vast majority of pediatric visits and antibiotics ordered or prescribed to children occur in 
non-pediatric EDs, highlighting the important role of non-pediatric emergency medicine 
practitioners in improving the quality of antibiotic prescribing for children nationally. 
Pediatric antibiotic stewardship efforts in non-pediatric EDs have the potential to eliminate 
over 2 million unnecessary antibiotic prescriptions annually and increase the rates of 
guideline-concordant antibiotic use among children seen in this setting. Macrolides are 
frequently and inappropriately prescribed for children in EDs, and non-pediatric EDs in 
particular. Antibiotic stewardship efforts should expand to EDs nationwide, particularly 
regarding avoidance of antibiotic prescribing for treatment of conditions for which 
antibiotics are not indicated, reducing macrolide use, and increasing first line, guideline-
concordant prescribing for children, especially in non-pediatric EDs.
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What’s Known on This Subject:
Children are often prescribed antibiotics in EDs. Previous work has examined antibiotic 
prescribing in EDs for particular diagnostic conditions (e.g., pneumonia), but a 
comprehensive national evaluation of all antibiotic prescribing for children in pediatric 
and non-pediatric EDs is lacking.
What This Study Adds:
Children are prescribed over 2 million antibiotics annually in non-pediatric EDs that are 
likely unnecessary. Compared to pediatric EDs, non-pediatric EDs prescribe more 
macrolides and fewer guideline-concordant antibiotics for common illnesses. Pediatric 
antibiotic stewardship efforts are needed in EDs nationwide.
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Figure 1: Percent of antibiotic visits by antibiotic class for ED visits by children, by ED type, 
United States, 2009–2014.
Shading represents antibiotic class: dark grey are penicillins, light grey are cephalosporins, 
grey/white checkered are macrolides, black/white dotted are sulfonamides, white/grey 
diamonds are clindamycin (lincomycin derivative), and lightest grey are all other antibiotics. 
*P≤0.05 in comparison of non-pediatric versus pediatric ED. **Percentages sum to >100% 
because of co-prescribing at some visits.
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Figure 2: Percent of antibiotic visits by antibiotic class for ED visits by children over time, 
United States, 2009–2014.
*Antibiotic visits were defined as visits in which antibiotics were mentioned as continued, 
administered, or prescribed. **2-year increments used to assess change in antibiotic 
prescriptions over time. No significant change in percentages over the study period.
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Table 1:
Characteristics of visits to EDs by children 0–17 years of age, United States, 2009–2014.
Characteristic
Average annual number of visits by 
children, in millions (95% CI)
Percentage of visits by children that 
resulted in an antibiotic prescription 
(95% CI)
Total 29 (27–32) 23% (22–24%)
Age (years)
 <1 3.6 (3.2–4.0) 22% (20–24%)
 1–4 9.6 (8.6–10.5) 29% (27–30%)
 5–12 9.4 (8.5–10.3) 23% (22–24%)
 13–17 6.7 (6.0–7.3) 17% (16–19%)
Gender
 Male 15.3 (13.9–16.7) 22% (22–23%)
 Female 13.9 (12.6–15.2) 24% (23–25%)
Race
 White 20.2 (18.2–22.1) 23% (22–24%)
 Black 7.7 (6.6–8.8) 24% (23–26%)
 Other 1.4 (1.1–1.6) 20% (17–23%)
Insurance Status
 Private 8.7 (7.8–9.6) 20% (19–21%)
 Non-private 18.8 (16.9–20.7) 25% (24–26%)
US Census Region+
 Northeast 4.6 (3.9–5.3) 19% (17–20%)
 Midwest 6.5 (5.3–7.6) 24% (22–25%)
 South 12.0 (10.0–14.0) 25% (24–27%)
 West 6.1 (5.0–7.2) 22% (20–24%)
Metropolitan Statistical Area (MSA)*
 Non-MSA 5.0 (3.2–6.9) 27% (25–29%)
 MSA 24.7 (21.5–27.8) 23% (22–24%)
Type of ED
 Non-Pediatric 25.1 (22.8–27.3) 24% (23–25%)
 Pediatric 4.1 (2.6–5.7) 20% (17–22%)
Advanced Practice Practitioner Present at ED 
Visit
 No 23.7 (21.4–26.0) 23% (22–24%)
 Yes 5.3 (4.6–6.0) 26% (24–28%)
+U.S. Census Regions defined by the U.S. Census Bureau20
*
Data on MSA were not publicly available in 2012; therefore, estimates exclude observations from 2012.
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Table 2:
Percent of ED visits and antibiotic visits by diagnosis category and tier*, stratified by ED type, United States, 
2009–2014.
Percent of visits in which the diagnosis category or 
tier was used, among all visits involving children
Percent of antibiotic visits in which the 
diagnosis category or tier was used, among 
all antibiotic visits
Diagnosis Category Non-pediatric ED (95% CI)
Pediatric ED (95% CI) p (χ2) Non-pediatric ED (95% CI)
Pediatric ED 
(95% CI) p (χ2)
ARTI 26% (25–27%) 28% (26–31%) 0.16 55% (53–57%) 57% (51–62%) 0.55
SSTI 2% (2–2%) 2% (1–2%) 0.38 9% (8–10%) 9% (6–12%) 0.39
UTI 3% (3–3%) 3% (2–4%) 0.43 7% (6–8%) 8% (6–10%) 0.99
Other Conditions 69% (68–70%) 67% (64–70%) 0.31 29% (28–31%) 27% (22–32%) 0.34
Diagnosis Tier* Non-pediatric ED (95% CI)
Pediatric ED(95% CI) p (χ2) Non-pediatric ED (95% CI)
Pediatric ED 
(95% CI) p (χ2)
Antibiotics always indicated 10% (9–10%) 11% (9–12%) 0.28 16% (15–18%) 17% (14–20%) 0.02
Antibiotics may be indicated 23% (22–24%) 24% (22–27%) 51% (49–53%) 57% (52–62%)
Antibiotics generally not 
indicated 67% (66–68%) 65% (62–68%) 33% (31–34%) 26% (21–31%)
ARTI: acute respiratory tract infection;
SSTI: skin and soft tissue infection;
UTI: urinary tract infection
*Classification of diagnosis tier is based on a previously published hierarchical system informed by national guideline recommendations (Fleming-
Dutra 2016).
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Table 3:
Factors associated with first-line, guideline-concordant antibiotic prescribing for acute otitis media, sinusitis, 
and pharyngitis in ED visits by children, United States, 2009–2014.
Characteristic*
Percentage of visits in which first-line, 
guideline-concordant antibiotics were 
prescribed, among all visits in which 
antibiotics were prescribed (95% CI) p(χ2)
Adjusted Odds Ratio (95% CI) for 
first-line, guideline-concordant 
prescribing
Age (years) 0.12
 <1 80% (74–85%) 1.00
 1–4 80% (76–83%) 1.07 (0.68–1.70)
 5–12 78% (74–81%) 1.11 (0.68–1.82)
 13–17 72% (66–77%) 0.92 (0.49–1.72)
Sex 0.89
 Male 78% (75–81%) 1.00
 Female 78% (75–81%) 1.01 (0.78–1.30)
Race <0.01
 White 76% (73–79%) 1.00
 Black 81% (75–85%) 1.56 (1.15–2.11)
Insurance status 0.08
 Private 75% (70–79%) 1.00
 Non-private 79% (76–82%) 1.32 (0.99–1.76)
US Census Region+ 0.04
 Northeast 86% (83–89%) 1.00
 Midwest 78% (74–83%) 0.51 (0.34–0.77)
 South 76% (72–80%) 0.46 (0.32–0.67)
 West 77% (72–82%) 0.55 (0.35–0.87)
Advanced Practice Practitioner present at 
ED Visit 0.58
 No 78% (75–80%) 1.00
 Yes 79% (75–83%) 1.08 (0.84–1.39)
Type of ED <0.001
 Non-Pediatric 77% (75–79%) 1.00
 Pediatric 87% (82–90%) 2.01 (1.38–2.92)
Diagnosis <0.01
 Acute Otitis Media 81% (78–84%) 1.00
 Sinusitis 70% (60–78%) 0.51 (0.32–0.82)
 Pharyngitis 74% (71–78%) 0.72 (0.53–0.96)
Modeled using 2009–11 and 2013–14
Metropolitan Statistical Area (MSA) <0.001
 Non-MSA 71% (68–75%) 1.00
 MSA 79% (75–80%) 1.26 (0.99–1.60)
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*
Data on MSA were not publicly available in 2012. The main model to determine the odds ratio estimates for each variable included all listed 
variables other than MSA. Odds ratio estimates for MSA are from a separate model that adjusted for all other variables, but excluded observations 
from 2012.
+U.S. Census Regions defined by the U.S. Census Bureau20
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